The flow diagram of index construction is showed in the Figure 2A. Firstly, Herceptin-resistant HER2+ BC cell lines were established by low dose Herceptin treatment (5 μg/ml) for more than 6 months (Figure S2A; Figure S3A). Here, ERBB2 is linked to breast cancer.